0

    524731

    JENBURPH

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JENBURKT PHARMACEUTICALS LTD. Share Price Today

    Investment Returns

    Over 1 Month -4.97% Over 3 Months 0.95% Over 6 Months 0.58% Over 1 Year -18.28%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JENBURKT PHARMACEUTICALS LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 473.10
    • P/E Ratio (TTM) 13.69
    • Beta 0.81
    • Book Value / share 446.47
    • Return on equity 20.25%
    • EPS (TTM) 85.23
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 10.85
    info icon alternate text

    JENBURKT PHARMACEUTICALS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 44.63
    Operating Expense 31.32
    Net Profit 10.85
    Net Profit Margin (%) 24.31
    Earnings Per Share (EPS) 24.58
    EBITDA 14.65
    Effective Tax Rate (%) 20.86
    Particulars DEC 2025 (Values in Cr)
    Revenue 43.02
    Operating Expense 36.55
    Net Profit 5.93
    Net Profit Margin (%) 13.78
    Earnings Per Share (EPS) 13.44
    EBITDA 9.25
    Effective Tax Rate (%) 28.55
    Particulars SEP 2025 (Values in Cr)
    Revenue 45.56
    Operating Expense 33.31
    Net Profit 10.16
    Net Profit Margin (%) 22.30
    Earnings Per Share (EPS) 23.03
    EBITDA 15.18
    Effective Tax Rate (%) 29.09
    Particulars JUN 2025 (Values in Cr)
    Revenue 35.53
    Operating Expense 27.40
    Net Profit 7.79
    Net Profit Margin (%) 21.92
    Earnings Per Share (EPS) 17.66
    EBITDA 11.01
    Effective Tax Rate (%) 23.47
    Particulars MAR 2025 (Values in Cr)
    Revenue 41.05
    Operating Expense 31.09
    Net Profit 8.54
    Net Profit Margin (%) 20.80
    Earnings Per Share (EPS) 19.34
    EBITDA 12.73
    Effective Tax Rate (%) 27.87
    Particulars MAR 2026 (Values in Cr)
    Revenue 168.74
    Operating Expense 128.57
    Net Profit 34.74
    Net Profit Margin (%) 20.58
    Earnings Per Share (EPS) 78.71
    EBITDA 50.09
    Effective Tax Rate (%) 25.32
    Particulars MAR 2025 (Values in Cr)
    Revenue 151.69
    Operating Expense 114.48
    Net Profit 32.06
    Net Profit Margin (%) 21.13
    Earnings Per Share (EPS) 72.65
    EBITDA 47.11
    Effective Tax Rate (%) 27.02
    Particulars MAR 2024 (Values in Cr)
    Revenue 141.97
    Operating Expense 111.46
    Net Profit 25.98
    Net Profit Margin (%) 18.29
    Earnings Per Share (EPS) 58.86
    EBITDA 37.79
    Effective Tax Rate (%) 26.15
    Particulars MAR 2023 (Values in Cr)
    Revenue 136.75
    Operating Expense 109.01
    Net Profit 24.61
    Net Profit Margin (%) 17.99
    Earnings Per Share (EPS) 53.90
    EBITDA 35.48
    Effective Tax Rate (%) 25.13
    Particulars MAR 2022 (Values in Cr)
    Revenue 123.98
    Operating Expense 99.05
    Net Profit 22.30
    Net Profit Margin (%) 17.98
    Earnings Per Share (EPS) 48.58
    EBITDA 32.20
    Effective Tax Rate (%) 25.34
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 389.23
    ROE % 20.25
    ROCE % 27.18
    Total Debt to Total Equity 0.01
    EBITDA Margin 31.06
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 328.42
    ROE % 19.44
    ROCE % 25.67
    Total Debt to Total Equity 0.01
    EBITDA Margin 26.62
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 277.32
    ROE % 20.53
    ROCE % 26.04
    Total Debt to Total Equity 0.04
    EBITDA Margin 25.95
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 255.77
    ROE % 20.66
    ROCE % 25.94
    Total Debt to Total Equity 0.05
    EBITDA Margin 25.97
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 214.55
    ROE % 18.49
    ROCE % 22.77
    Total Debt to Total Equity 0.05
    EBITDA Margin 22.10
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 24.64
    Total Assets 196.18
    Total Liabilities 196.18
    Total Equity 171.77
    Share Outstanding 0
    Price to Book Ratio 2.60
    Return on Assets (%) 16.34
    Return on Capital (%) 18.45
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 79.19
    Total Assets 165.09
    Total Liabilities 165.09
    Total Equity 144.94
    Share Outstanding 0
    Price to Book Ratio 2.10
    Return on Assets (%) 15.73
    Return on Capital (%) 17.92
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 53.80
    Total Assets 141.81
    Total Liabilities 141.81
    Total Equity 122.38
    Share Outstanding 0
    Price to Book Ratio 2.40
    Return on Assets (%) 17.35
    Return on Capital (%) 19.71
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 49.02
    Total Assets 142.94
    Total Liabilities 142.94
    Total Equity 117.38
    Share Outstanding 0
    Price to Book Ratio 2.22
    Return on Assets (%) 15.59
    Return on Capital (%) 18.1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 56.50
    Total Assets 121.18
    Total Liabilities 121.18
    Total Equity 98.46
    Share Outstanding 0
    Price to Book Ratio 1.86
    Return on Assets (%) 13.61
    Return on Capital (%) 16.15
    Particulars MAR 2025 (Values in Cr)
    Net Income 32.06
    Cash from Operations 41.33
    Cash from Investing -17.04
    Cash from Financing -7.62
    Net change in Cash 3.23
    Free Cash Flow 61.05
    Particulars MAR 2024 (Values in Cr)
    Net Income 25.97
    Cash from Operations 16.38
    Cash from Investing -0.58
    Cash from Financing -7.07
    Net change in Cash 0.46
    Free Cash Flow 18.94
    Particulars MAR 2023 (Values in Cr)
    Net Income 24.60
    Cash from Operations 25.27
    Cash from Investing 2.61
    Cash from Financing -21.04
    Net change in Cash -1.37
    Free Cash Flow 27.38
    Particulars MAR 2022 (Values in Cr)
    Net Income 22.29
    Cash from Operations 16.83
    Cash from Investing -1.20
    Cash from Financing -5.53
    Net change in Cash 2.53
    Free Cash Flow 19.88
    Particulars MAR 2021 (Values in Cr)
    Net Income 16.50
    Cash from Operations 25.29
    Cash from Investing -18.78
    Cash from Financing -0.71
    Net change in Cash -0.04
    Free Cash Flow 26.43
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.49 13.07 1.52 241.32 23.12 38.85
    BLISS GVS PHARMA LTD. 448.15 36.02 3.98 4752.91 118.35 552.90
    CIPLA LTD 1415.10 30.03 3.32 114318.19 1165.55 1672.20
    FERMENTA BIOTECH LTD. 420.85 18.56 3.04 1238.60 256.40 480.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2551.10 44.91 19.06 43217.17 2088.00 3217.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.49 22.02 4.05 241.32 23.12 38.85
    AMRUTAJAN HEALTH LTD 529.35 23.73 4.13 1530.38 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8033.05 104.91 23.00 20082.63 7630.00 9850.00
    BLISS GVS PHARMA LTD. 448.15 48.45 4.11 4752.91 118.35 552.90

    JENBURKT PHARMACEUTICALS LTD. shareholding pattern

    Holding
    53.25%
    46.61%
    0.12%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    JENBURKT PHARMACEUTICALS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1071.95 -0.51 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 1082.50
    • 26 Days 1106.80
    • 10 Days 1090.00
    • 50 Days 1111.30
    • 12 Days 1092.70
    • 100 Days 1105.60
    • 20 Days 1102.10
    • 200 Days 1105.80
    1076.25 PIVOT
    First Support 1045.60 First Resistance 1098.20 Second Support 1023.65 Second Resistance 1128.85 Third Support 993.00 Third Resistance 1150.80
    RSI 35.95 ADX 16.82 MACD -13.76 Williams % R -83.60 Commodity Channel Index (CCI) -188.75
    Date 2026-07-22 Week 683.00 Same Day 590.00 Month 795.00
    1 Year 0.82 3 Year 0.78
    Over 1 Month
    -4.97% down
    Over 1 Year
    -18.28% down
    Over 3 Months
    0.95% down
    Over 3 Years
    12.63% down
    Over 6 Months
    0.58% down
    Over 5 Years
    15.73% down

    JENBURKT PHARMACEUTICALS LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    11 Jul 2025 18.0 Final 11 Jul 2025 Equity shares
    23 Jul 2024 15.3 Final 24 Jul 2024 Equity shares
    19 Jul 2023 14.4 Final 20 Jul 2023 Equity shares
    21 Jul 2022 12.0 Final 23 Jul 2022 Equity shares
    30 Aug 2021 10.2 Final 01 Sep 2021 Equity shares
    18 Mar 2020 8.1 Interim 19 Mar 2020 Equity shares
    22 Jul 2019 10.2 Final 24 Jul 2019 Equity shares
    23 Jul 2018 6.0 Final 25 Jul 2018 Equity shares
    27 Mar 2018 3.0 Interim 28 Mar 2018 Equity shares
    21 Jul 2017 8.1 Final 25 Jul 2017 Equity shares
    19 Jul 2016 0.9 Final 21 Jul 2016 Equity shares
    17 Mar 2016 6.3 Interim 18 Mar 2016 Equity shares
    31 Aug 2015 6.3 Final 02 Sep 2015 Equity shares
    03 Sep 2014 5.1 Final 05 Sep 2014 Equity shares
    18 Sep 2013 4.2 Final 20 Sep 2013 Equity shares
    23 Jul 2012 3.5 Final 25 Jul 2012 Equity shares
    21 Jul 2011 3.5 Final 23 Jul 2011 Equity shares
    21 Jul 2010 3.0 Final 23 Jul 2010 Equity shares
    23 Jul 2009 1.8 Final 25 Jul 2009 Equity shares
    23 Jul 2008 1.25 Final 25 Jul 2008 Equity shares
    18 Jul 2007 1.25 Final 20 Jul 2007 Equity shares
    10 Aug 2005 0.0 Final 12 Aug 2005 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Jenburkt Pharmaceuticals Ltd?

    Answer Field

    Jenburkt Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1,071.95 as on Jul 24 2026 10:33 AM.

    What is the Market Cap of Jenburkt Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Jenburkt Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 473.10 as on Jul 24 2026 10:33 AM.

    What is the 52 Week High and Low of Jenburkt Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Jenburkt Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1,364.90 and ₹ 944.00.

    What is 1 year return for Jenburkt Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -18.93%.

    What is the P/E Ratio of Jenburkt Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 24 2026 10:33 AM the price-to-earnings (PE) ratio for Jenburkt Pharmaceuticals Ltd share is 13.69.

    What is the PB ratio of Jenburkt Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 24 2026 10:33 AM, the price-to-book (PB) ratio for Jenburkt Pharmaceuticals Ltd share is 446.47.

    How to Buy Jenburkt Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Jenburkt Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Jenburkt Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Jenburkt Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Jenburkt Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |